A Study to Describe the Safety and Effectiveness of Venetoclax in Acute Myeloid Leukemia (AML) Patients (REVIVE Study)

Last updated: January 8, 2025
Sponsor: AbbVie
Overall Status: Active - Recruiting

Phase

N/A

Condition

Acute Myeloid Leukemia

Leukemia

Platelet Disorders

Treatment

N/A

Clinical Study ID

NCT03987958
P19-831
  • Ages > 18
  • All Genders

Study Summary

This study will describe the safety and effectiveness of venetoclax in AML patients in routine clinical practice in Israel. The decision to treat with venetoclax is made by the physician prior to any decision regarding participation in this study.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Participant diagnosed with Acute Myeloid Leukemia (AML) and is eligible to receivevenetoclax per Israel Ministry of Health.

  • Participant who will be treated with venetoclax and the decision to treat withvenetoclax is made by the physician prior to any decision regarding participation inthis study.

Exclusion

Exclusion Criteria:

  • Participant participating in an interventional trial within 30 days prior tostarting venetoclax treatment.

Study Design

Total Participants: 100
Study Start date:
August 08, 2019
Estimated Completion Date:
July 31, 2027

Connect with a study center

  • HaEmek Medical Center /ID# 213370

    Afula, H_efa 1834111
    Israel

    Site Not Available

  • Bnai Zion Medical Center /ID# 213344

    Haifa, H_efa 3339419
    Israel

    Site Not Available

  • Rambam Health Care Campus /ID# 213355

    Haifa, H_efa 3109601
    Israel

    Site Not Available

  • Soroka University Medical Center /ID# 213369

    Be'er Sheva, HaDarom 8443901
    Israel

    Site Not Available

  • Meir Medical Center /ID# 213352

    Kfar Saba, HaMerkaz 4428164
    Israel

    Active - Recruiting

  • Assuta Tel Aviv Medical Center /ID# 213371

    Tel Aviv, HaMerkaz 6971028
    Israel

    Site Not Available

  • ZIV Medical Center /ID# 229211

    Safed, HaTsafon 13100
    Israel

    Completed

  • Rabin Medical Center /ID# 213343

    Petah Tikva, Tel-Aviv 4941492
    Israel

    Site Not Available

  • The Chaim Sheba Medical Center /ID# 213353

    Ramat Gan, Tel-Aviv 5265601
    Israel

    Site Not Available

  • Tel Aviv Sourasky Medical Center /ID# 213354

    Tel Aviv, Tel-Aviv 6423906
    Israel

    Site Not Available

  • Tel Aviv Sourasky Medical Center /ID# 213354

    Tel Aviv-Yafo, Tel-Aviv 6423906
    Israel

    Site Not Available

  • Hadassah /ID# 213356

    Jerusalem, Yerushalayim 91120
    Israel

    Site Not Available

  • Shaare Zedek Medical Center /ID# 228016

    Jerusalem, Yerushalayim 91031
    Israel

    Site Not Available

  • Rabin Medical Center /ID# 213343

    Haifa, 4941492
    Israel

    Site Not Available

  • Rabin Medical Center /ID# 213343

    Petakh Tikva, 4941492
    Israel

    Site Not Available

  • Ziv Medical Center /ID# 229211

    Safed, 13100
    Israel

    Site Not Available

  • Sourasky Medical Center /ID# 213354

    Tel-aviv, 62439
    Israel

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.